Consulting Agreements in the Biotechnology Industry

1,089 Contracts & Agreements

Browse by Company

2seventy bio, Inc. (1 contract)
Accustem Sciences Inc. (3)
Achaogen, Inc. (1)
Acorda Therapeutics (3)
Actinium Pharmaceuticals, Inc. (3)
Adagio Therapeutics, Inc. (2)
Adamas Pharmaceuticals Inc (7)
Adaptimmune Therapeutics PLC (1)
Adhera Therapeutics, Inc. (2)
ADiTx Therapeutics, Inc. (4)
ADMA BIOLOGICS, INC. (1)
ADURO BIOTECH, INC. (3)
Advaxis, Inc. (1)
Adverum Biotechnologies, Inc. (10)
Aeglea BioTherapeutics, Inc. (6)
AGENUS INC (11)
AgeX Therapeutics, Inc. (1)
AGIOS PHARMACEUTICALS INC (2)
AILERON THERAPEUTICS INC (2)
AKCEA THERAPEUTICS, INC. (4)
Akebia Therapeutics, Inc. (2)
Akouos, Inc. (1)
ALBIREO PHARMA, INC. (2)
Aldeyra Therapeutics, Inc. (2)
Alector, Inc. (1)
Alexion Pharmaceuticals (2)
Aligos Therapeutics, Inc. (2)
Allarity Therapeutics, Inc. (1)
Alliqua BioMedical, Inc. (7)
Allogene Therapeutics, Inc. (3)
Allovir, Inc. (4)
ALNYLAM PHARMACEUTICALS, INC. (2)
Altimmune, Inc. (3)
Alzamend Neuro, Inc. (1)
AMARILLO BIOSCIENCES INC (3)
AMARIN CORP PLC (1)
Amgen Inc. (3)
AMICUS THERAPEUTICS, INC. (2)
AmpliPhi Biosciences Corp (1)
ANAPTYSBIO INC (2)
ANAVEX LIFE SCIENCES CORP. (9)
Anchiano Therapeutics Ltd. (1)
Anika Therapeutics (3)
Apellis Pharmaceuticals, Inc. (2)
Applied Molecular Transport Inc. (1)
Aptose Biosciences Inc. (1)
AquaBounty Technologies, Inc. (1)
AQUINOX PHARMACEUTICALS, INC (7)
Aravive, Inc. (3)
Arbutus Biopharma Corp (3)
ARCA biopharma, Inc. (2)
Arcellx, Inc. (1)
Arcus Biosciences, Inc. (4)
Arcutis Biotherapeutics, Inc. (1)
ARENA PHARMACEUTICALS INC (2)
Arsanis, Inc. (1)
Artiva Biotherapeutics, Inc. (1)
ASSEMBLY BIOSCIENCES, INC. (3)
Atara Biotherapeutics, Inc. (1)
Athenex, Inc. (2)
ATHERSYS, INC (1)
Atreca, Inc. (4)
Aura Biosciences, Inc. (1)
AVEO PHARMACEUTICALS INC (3)
Avidity Biosciences, Inc. (1)
AVROBIO, Inc. (2)
AzurRx BioPharma, Inc. (1)
BeiGene, Ltd. (6)
BELLICUM PHARMACEUTICALS, INC (8)
BICYCLE THERAPEUTICS Ltd (1)
bioAffinity Technologies, Inc. (2)
BioCardia, Inc. (2)
Biogen Inc. (3)
Biohaven Pharmaceutical Holding Co Ltd. (1)
BIOMARIN PHARMACEUTICAL INC (3)
BioNexus Gene Lab Coporation (1)
BioRestorative Therapies, Inc. (1)
BIOSPECIFICS TECHNOLOGIES CORP (3)
Biostage, Inc. (1)
BIOTIME INC (7)
BioXcel Therapeutics, Inc. (1)
BIOXYTRAN, INC (1)
Blue Water Vaccines Inc. (3)
bluebird bio, Inc. (2)
Blueprint Medicines Corp (1)
Bolt Biotherapeutics, Inc. (3)
Bone Biologics Corp (3)
BRAINSTORM CELL THERAPEUTICS INC. (1)
BridgeBio Pharma, Inc. (1)
BullFrog AI Holdings, Inc. (1)
BURZYNSKI RESEARCH INSTITUTE INC (1)
C4 Therapeutics, Inc. (1)
Cabaletta Bio, Inc. (2)
CALADRIUS BIOSCIENCES, INC. (2)
Calyxt, Inc. (2)
CANCER GENETICS, INC (7)
Candel Therapeutics, Inc. (3)
CAPRICOR THERAPEUTICS, INC. (2)
Capstone Therapeutics Corp. (1)
CareDx, Inc. (4)
CASTLE BIOSCIENCES INC (1)
Castle Creek Biosciences, Inc. (3)
CATABASIS PHARMACEUTICALS INC (2)
CATALYST BIOSCIENCES, INC. (3)
CATALYST PHARMACEUTICALS, INC. (4)
Cellectar Biosciences, Inc. (1)
Cellular Biomedicine Group, Inc. (1)
Celsion CORP (3)
CEREBAIN BIOTECH CORP. (2)
Chardan Healthcare Acquisition 2 Corp. (2)
CHIMERIX INC (3)
Cidara Therapeutics, Inc. (2)
CLEVELAND BIOLABS INC (5)
CohBar, Inc. (3)
Conatus Pharmaceuticals Inc. (2)
CONSTELLATION PHARMACEUTICALS INC (3)
CONTRAFECT Corp (3)
Corbus Pharmaceuticals Holdings, Inc. (1)
Corvus Pharmaceuticals, Inc. (1)
Crinetics Pharmaceuticals, Inc. (1)
CRISPR Therapeutics AG (1)
CTI BIOPHARMA CORP (1)
Cue Biopharma, Inc. (3)
Cullinan Oncology, LLC (5)
Curative Biotechnology Inc (3)
CURIS INC (13)
Cyclacel Pharmaceuticals, Inc. (1)
Cyclerion Therapeutics, Inc. (1)
CytoDyn Inc. (8)
Cytokinetics, Incorporated (4)
CytomX Therapeutics, Inc. (7)
CYTORI THERAPEUTICS, INC. (3)
Decibel Therapeutics, Inc. (2)
Deciphera Pharmaceuticals, Inc. (1)
DelMar Pharmaceuticals, Inc. (8)
Design Therapeutics, Inc. (5)
DiaMedica Therapeutics Inc. (2)
Diffusion Pharmaceuticals Inc. (5)
Digital Development Partners, Inc. (1)
Dynamics Special Purpose Corp. (3)
DYNAVAX TECHNOLOGIES CORP (3)
Dyne Therapeutics, Inc. (1)
Eagle Pharmaceuticals, Inc. (1)
Edge Therapeutics, Inc. (4)
Editas Medicine, Inc. (1)
Eiger BioPharmaceuticals, Inc. (1)
Eliem Therapeutics, Inc. (3)
Emergent BioSolutions Inc. (6)
Enanta Pharmaceuticals, Inc. (2)
Enochian Biosciences Inc (7)
Entera Bio Ltd. (2)
ENZOLYTICS INC (1)
Epizyme, Inc. (8)
Evelo Biosciences, Inc. (3)
EXACT SCIENCES CORP (1)
Exelixis (2)
EXICURE, INC. (1)
FATE THERAPEUTICS INC (1)
FIBROGEN INC (3)
Finch Therapeutics Group, Inc. (1)
FIVE PRIME THERAPEUTICS INC (4)
Flex Pharma, Inc. (2)
Flexion Therapeutics Inc (1)
FLUOROPHARMA MEDICAL, INC. (1)
Foghorn Therapeutics Inc. (4)
Fortress Biotech, Inc. (1)
FS Development Corp. II (2)
G1 Therapeutics, Inc. (1)
Gain Therapeutics, Inc. (2)
GALECTIN THERAPEUTICS INC (6)
Gamida Cell Ltd. (3)
Gemphire Therapeutics Inc. (3)
Generation Bio Co. (3)
GENOCEA BIOSCIENCES, INC. (3)
Genprex, Inc. (1)
GeoVax Labs, Inc. (4)
GERON CORP (1)
GLYCOMIMETICS INC (2)
Grail, Inc. (1)
Greater Cannabis Company, Inc. (2)
GTX INC (3)
GX Acquisition Corp. (1)
Harpoon Therapeutics, Inc. (3)
Health Sciences Acquisitions Corp (1)
HedgePath Pharmaceuticals, Inc. (1)
HEMISPHERX BIOPHARMA INC (2)
HISTOGENICS CORP (2)
Homology Medicines, Inc. (3)
HUMANIGEN, INC (2)
iBio, Inc. (2)
IDEAYA Biosciences, Inc. (1)
IDERA PHARMACEUTICALS, INC. (10)
Imago BioSciences, Inc. (1)
Immune Therapeutics, Inc. (8)
ImmunoCellular Therapeutics, Ltd. (2)
Immunome Inc. (2)
IMMUNOMEDICS INC (1)
INFINITY PHARMACEUTICALS, INC. (3)
Inhibikase Therapeutics, Inc. (2)
InMed Pharmaceuticals Inc. (5)
Inmune Bio, Inc. (1)
INOVIO PHARMACEUTICALS, INC. (1)
Inozyme Pharma, Inc. (3)
INSMED Inc (1)
INTERCEPT PHARMACEUTICALS, INC. (8)
International Stem Cell CORP (4)
Invitae Corp (1)
IOVANCE BIOTHERAPEUTICS, INC. (5)
IRONWOOD PHARMACEUTICALS INC (3)
Isoray, Inc. (2)
iTeos Therapeutics, Inc. (2)
Janux Therapeutics, Inc. (1)
Karyopharm Therapeutics Inc. (11)
KBL MERGER CORP. IV (10)
Kezar Life Sciences, Inc. (1)
Kiniksa Pharmaceuticals, Ltd. (1)
Kiromic Biopharma, Inc. (5)
KIWA BIO-TECH PRODUCTS GROUP CORP (1)
Kronos Bio, Inc. (1)
Leisure Acquisition Corp. (1)
LEXICON PHARMACEUTICALS, INC. (2)
LianBio (1)
LifeSci Acquisition Corp. (1)
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (2)
Locust Walk Acquisition Corp. (1)
LogicBio Therapeutics, Inc. (2)
LONGEVERON LLC (1)
MACROGENICS INC (1)
MANHATTAN SCIENTIFICS INC (1)
MARIZYME INC (4)
Marker Therapeutics, Inc. (5)
MATEON THERAPEUTICS INC (6)
Matinas BioPharma Holdings, Inc. (2)
MAXCYTE, INC. (1)
MEDICINOVA INC (5)
Medovex Corp. (2)
MeiraGTx Holdings plc (1)
MERRIMACK PHARMACEUTICALS INC (1)
Merus N.V. (2)
Metacrine, Inc. (4)
Millendo Therapeutics, Inc. (3)
MiMedx Group, Inc. (4)
Minerva Neurosciences, Inc. (5)
MIRAGEN THERAPEUTICS, INC. (4)
Mirati Therapeutics, Inc. (3)
Mirum Pharmaceuticals, Inc. (1)
Moderna, Inc. (3)
Moleculin Biotech, Inc. (1)
Momenta Pharmaceuticals, Inc. (5)
Monopar Therapeutics (11)
Morphic Holding, Inc. (3)
MYMETICS CORP (1)
Myovant Sciences Ltd. (2)
Myriad Genetics, Inc. (4)
NAVIDEA BIOPHARMACEUTICALS, INC. (3)
NEUROBIOLOGICAL TECHNOLOGIES INC (1)
Neurotrope, Inc. (6)
NextCure, Inc. (2)
NOVAVAX INC (7)
Novus Therapeutics, Inc. (3)
NTN BUZZTIME INC (8)
Nuo Therapeutics, Inc. (2)
Ohr Pharmaceutical Inc (2)
Olema Pharmaceuticals, Inc. (1)
Olivia Ventures, Inc. (2)
Omega Therapeutics, Inc. (4)
OncBioMune Pharmaceuticals, Inc (5)
OncoCyte Corp (2)
OPGEN INC (3)
Ophthotech Corp. (2)
Organicell Regenerative Medicine, Inc. (4)
ORGANOVO HOLDINGS, INC. (6)
Orgenesis Inc. (6)
Outlook Therapeutics, Inc. (5)
Ovid Therapeutics Inc. (1)
Pasithea Therapeutics Corp. (2)
Passage BIO, Inc. (2)
PDL BIOPHARMA, INC. (1)
PharmaCyte Biotech, Inc. (6)
PIERIS PHARMACEUTICALS, INC. (4)
PLURISTEM THERAPEUTICS INC (6)
PMV Pharmaceuticals, Inc. (5)
POLARITYTE, INC. (2)
PORTOLA PHARMACEUTICALS INC (1)
PRECISION BIOSCIENCES INC (2)
PREDICTIVE TECHNOLOGY GROUP, INC. (1)
Prelude Therapeutics Inc (1)
PREMIER BIOMEDICAL INC (1)
Progenics Pharmaceuticals, Inc. (2)
Protagenic Therapeutics, Inc. (7)
PROTEON THERAPEUTICS INC (3)
PROTEOSTASIS THERAPEUTICS, INC. (4)
Prothena Corp plc (5)
ProtoKinetix, Inc. (15)
PTC THERAPEUTICS, INC. (4)
Q BioMed Inc. (1)
Qrons Inc. (2)
Radius Health, Inc. (7)
Rallybio Corp (1)
RAPT Therapeutics, Inc. (2)
REGENXBIO Inc. (1)
Regulus Therapeutics Inc. (1)
Reneo Pharmaceuticals, Inc. (6)
RenovaCare, Inc. (8)
RenovoRx, Inc. (8)
Replimune Group, Inc. (4)
Retrophin, Inc. (1)
REXAHN PHARMACEUTICALS, INC. (9)
RHYTHM PHARMACEUTICALS, INC. (3)
RIGEL PHARMACEUTICALS INC (1)
RITTER PHARMACEUTICALS INC (7)
ROCKET PHARMACEUTICALS, INC. (1)
Sage Therapeutics, Inc. (1)
Sana Biotechnology, Inc. (1)
Sarepta Therapeutics, Inc. (3)
Savara Inc (4)
Scholar Rock Holding Corp (1)
SEATTLE GENETICS INC (1)
SELECTA BIOSCIENCES INC (5)
SELLAS Life Sciences Group, Inc. (1)
Sensei Biotherapeutics, Inc. (1)
SERA PROGNOSTICS, INC. (2)
Seres Therapeutics, Inc. (1)
Sesen Bio, Inc. (4)
Shuttle Pharmaceuticals Holdings, Inc. (2)
Sierra Oncology, Inc. (1)
Sigilon Therapeutics, Inc. (3)
Silverback Therapeutics, Inc. (6)
SOLENO THERAPEUTICS INC (2)
Solid Biosciences Inc. (11)
SOLIGENIX, INC. (1)
Sorrento Therapeutics, Inc. (3)
Spectrum Pharmaceuticals, Inc. (1)
Spero Therapeutics, Inc. (8)
SPHERIX INC (1)
Spring Bank Pharmaceuticals, Inc. (3)
SpringWorks Therapeutics, Inc. (2)
SPRUCE BIOSCIENCES, INC. (1)
SQZ Biotechnologies Co (2)
Stoke Therapeutics, Inc. (1)
Sun BioPharma, Inc. (2)
SUNESIS PHARMACEUTICALS INC (5)
Syndax Pharmaceuticals Inc (1)
SYNLOGIC, INC. (1)
Synthetic Biologics, Inc. (3)
Syros Pharmaceuticals, Inc. (2)
TENAX THERAPEUTICS, INC. (6)
Therapeutics Acquisition Corp. (2)
Tonix Pharmaceuticals Holding Corp. (3)
Translate Bio, Inc. (3)
TREVENA INC (2)
Turning Point Therapeutics, Inc. (3)
U.S. Stem Cell, Inc. (2)
uniQure N.V. (2)
Unum Therapeutics Inc. (1)
USA EQUITIES CORP. (2)
Vaxart, Inc. (3)
VBI Vaccines Inc (10)
Vera Therapeutics, Inc. (1)
Verastem, Inc. (6)
Vericel Corp (1)
VICAL INC (12)
Viela Bio, Inc. (1)
VistaGen Therapeutics, Inc. (7)
VITRO DIAGNOSTICS INC (4)
Voyager Therapeutics, Inc. (13)
Xencor Inc (2)
Xenon Pharmaceuticals Inc. (1)
Xilio Therapeutics, Inc. (1)
XOMA Corp (2)
Yulong Eco-Materials Ltd (1)
Zentalis Pharmaceuticals, LLC (2)
ZIOPHARM ONCOLOGY INC (6)

Recent Contracts

Consulting Agreement, dated October 5, 2024, by and between the Company and Mark A. Demitrack, MD (TREVENA INC, Filed With SEC on October 10, 2024)
Consulting Agreement, dated October 5, 2024, by and between the Company and Barry Shin (TREVENA INC, Filed With SEC on October 10, 2024)
Consulting Agreement between BioXcel Therapeutics, Inc. and Matthew Wiley, dated October 8, 2024 (BioXcel Therapeutics, Inc., Filed With SEC on October 9, 2024)
Consulting Agreement, dated September 30, 2024, between CareDx, Inc. and Alexander Johnson (CareDx, Inc., Filed With SEC on October 4, 2024)
Scientific Advisory Board Consulting Agreement, dated as of September 4, 2024, between the Company and Barry Greenberg, Ph.D (InMed Pharmaceuticals Inc., Filed With SEC on September 30, 2024)
Consulting Agreement, dated as of May 17, 2024, between the Company and Alexandra D. J. Mancini, d.b.a True North Synergy Inc (InMed Pharmaceuticals Inc., Filed With SEC on September 30, 2024)
Consulting Agreement, dated September 13, 2024, with Jeffrey L. Wade (LEXICON PHARMACEUTICALS, INC., Filed With SEC on September 16, 2024)
Consulting Agreement, effective as of August 30, 2024, by and between Oruka Therapeutics, Inc. and Jeff Dekker (ARCA biopharma, Inc., Filed With SEC on September 5, 2024)
Consulting Agreement, dated as of August 29, 2024, between the Company and Michael Mason (Karyopharm Therapeutics Inc., Filed With SEC on August 29, 2024)
Consulting Agreement, dated August 21, 2024, by and between bioAffinity Technologies, Inc. and Michael Edwards (bioAffinity Technologies, Inc., Filed With SEC on August 23, 2024)
Consulting Agreement by and between the Company and Yvonne Li (Dynamics Special Purpose Corp., Filed With SEC on August 13, 2024)
Consulting Agreement by and between the Company and Deborah Knobelman, effective as of May 4, 2024 (Dynamics Special Purpose Corp., Filed With SEC on August 13, 2024)
Consulting Agreement, dated May 10, 2024, by and between the Registrant and Ashley F. Hall, J.D (Reneo Pharmaceuticals, Inc., Filed With SEC on August 13, 2024)
Consulting Agreement, dated May 10, 2024, by and between the Registrant and Michael P. Cruse (Reneo Pharmaceuticals, Inc., Filed With SEC on August 13, 2024)
Consulting Agreement, dated May 10, 2024, by and between the Registrant and Alejandro Dorenbaum, M.D (Reneo Pharmaceuticals, Inc., Filed With SEC on August 13, 2024)
Consulting Agreement, dated May 10, 2024, by and between the Registrant and Gregory J. Flesher (Reneo Pharmaceuticals, Inc., Filed With SEC on August 13, 2024)
Transition, Separation and Consulting Agreement, dated August 12, 2024, by and between Pascal Touchon and Atara Biotherapeutics, Inc (Atara Biotherapeutics, Inc., Filed With SEC on August 12, 2024)
Consulting Agreement, effective as of June 1, 2024, by and between the CervoMed Inc. and J. William Tanner, Ph.D (Diffusion Pharmaceuticals Inc., Filed With SEC on August 9, 2024)
Consulting Agreement, dated April 2, 2024, by and between the Registrant and Geoffrey O'Brien (MEDICINOVA INC, Filed With SEC on August 8, 2024)
Consulting Agreement, dated August 2, 2024, by and between the Company and James Sapirstein (AzurRx BioPharma, Inc., Filed With SEC on August 7, 2024)
Consulting Agreement by and between the Company and John J. Kuch, dated April 19, 2024 (Xencor Inc, Filed With SEC on August 5, 2024)
Amendment, dated as of June 8, 2024, to the Consulting Agreement by and between BioMarin Pharmaceutical Inc. and Jean-Jacques Bienaim, dated October 30, 2023 (BIOMARIN PHARMACEUTICAL INC, Filed With SEC on August 5, 2024)
Consulting and Employment Separation Agreement effective as of July 1, 2024 between the Registrant and Kenneth T. Mills (REGENXBIO Inc., Filed With SEC on August 1, 2024)
Form of Consulting Agreement (Rallybio Corp, Filed With SEC on July 23, 2024)
Consulting Agreement (VITRO DIAGNOSTICS INC, Filed With SEC on July 1, 2024)
Scientific Advisory and Consulting Agreement, executed as of June 18, 2024, by and between NextCure, Inc. and Dr. Han Myint, M.D (NextCure, Inc., Filed With SEC on June 18, 2024)
Consulting Agreement, dated June 10, 2024, between the Company and Karina Fedasz (Blue Water Vaccines Inc., Filed With SEC on June 14, 2024)
Consulting Agreement dated as of May 31, 2024 between the Company and Dr. Jan Schellens (LIXTE BIOTECHNOLOGY HOLDINGS, INC., Filed With SEC on June 5, 2024)
Consulting Agreement, dated May 28, 2024, by and between Compass Therapeutics, Inc. and Vered Bisker-Leib, PhD (Olivia Ventures, Inc., Filed With SEC on May 28, 2024)
Consulting Agreement, dated April 15, 2024, by and between Imunon, Inc. and Monomoy Advisors, LLC (Celsion CORP, Filed With SEC on May 20, 2024)
Retirement and Consulting Agreement, dated May 17, 2024, between Imunon, Inc. and Jeffrey Church (Celsion CORP, Filed With SEC on May 20, 2024)
Form of Consulting Agreement, effective as of June 1, 2024, by and between the Company and J. William Tanner, Ph.D (Diffusion Pharmaceuticals Inc., Filed With SEC on May 20, 2024)
Consulting Agreement, dated as of March 31, 2024, by and between Tanya Lewis and Replimune, Inc (Replimune Group, Inc., Filed With SEC on May 16, 2024)
Consulting Agreement, dated as of March 26, 2024, by and between Pamela Esposito and Replimune, Inc (Replimune Group, Inc., Filed With SEC on May 16, 2024)
Consulting Agreement, dated as of March 25, 2024, by and between Robert Coffin and Replimune, Inc (Replimune Group, Inc., Filed With SEC on May 16, 2024)
Consulting Agreement (James G. Cullem) (Allarity Therapeutics, Inc., Filed With SEC on May 14, 2024)
Scientific Advisory Board Consulting Agreement, dated as of April 12, 2024, between InMed Pharmaceuticals Inc. and David G. Morgan (InMed Pharmaceuticals Inc., Filed With SEC on May 14, 2024)
Consulting Agreement by and between the Registrant and Edith Perez, dated May 13, 2024 (Bolt Biotherapeutics, Inc., Filed With SEC on May 14, 2024)
Consulting Agreement by and between the Registrant and Randall C. Schatzman, dated May 13, 2024 (Bolt Biotherapeutics, Inc., Filed With SEC on May 14, 2024)
Consulting Agreement, by and between the registrant and Doug Kerr, dated February 1, 2024 (Generation Bio Co., Filed With SEC on May 13, 2024)